ADP-ribose

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameADP-ribose
Drug Alias NameADPR
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex modulatorsPoly (ADP-Ribose) polymerase modulators
TargetsPoly (ADP-Ribose) polymeraseNuclear factor NF-kappa-B complex
Therapy Area/IndicationsStomatitis +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsStomatitis +[2] 

Other Information

ATC CodeN/A
Related LinksN/A